Previous studies on experimental models of hyperammonemia or portocaval shunt in rats have demonstrated that the predominant mechanism of muscle depletion in these disorders were the increased activation of NF‐kB p65, with a subsequent higher expression of myostatin, a negative regulator of skeletal muscle mass (Qiu et al. Here, MSTN is linked to Hyperammonemia.